1. Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials. Issue 8 (25th May 2011) Authors: Heijl, C; Harper, L; Flossmann, O; Stücker, I; Scott, DGI; Watts, R A; Höglund, P; Westman, K; Mahr, A Journal: Annals of the rheumatic diseases Issue: Volume 70:Issue 8(2011) Page Start: 1415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Retrospective evaluation of continuation rates following a switch to subcutaneous methotrexate in rheumatoid arthritis patients failing to respond to or tolerate oral methotrexate: the MENTOR study. (November 2014) Authors: Scott, DGI; Claydon, P; Ellis, C Journal: Scandinavian journal of rheumatology Issue: Volume 43:Number 6(2014) Page Start: 470 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Retrospective evaluation of continuation rates following a switch to subcutaneous methotrexate in rheumatoid arthritis patients failing to respond to or tolerate oral methotrexate: the MENTOR study. (November 2014) Authors: Scott, DGI; Claydon, P; Ellis, C Journal: Scandinavian journal of rheumatology Issue: Volume 43:Number 6(2014) Page Start: 470 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗